Kieran McCafferty

Also affiliated with Barts Health NHS Trust, Royal London Hospital, William Harvey Research Institute, Royal London Hospital for Integrated Medicine

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy”.

Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

Kidney International Reports(2021)10.1016/j.ekir.2021.10.008

N/A

4.8DataRank · unranked

165 citations

Gerasimos Filippatos, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luís M. Ruilope +10 more

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Diabetes Care(2022)10.2337/dc21-1944

N/A

1.2DataRank · unranked

35 citations

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt +92 more